COLE JASON (Chief Legal Officer) sold 6.8% of their position (2.40K shares) of BLUEBIRD BIO, INC. on the open market
Open‑market sale worth $108.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 1/8/2021ACC: 0001562180-21-000265
Officer· Chief Legal Officer
Since Jul 2018
-2.40K
Net shares
Net seller
$108.2K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
2.40K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−43.00
Price / share
$44.95
Trade value
$1.93K
% of position
0.1%
1/5/2021
35.22K→35.18K
Common Stock
Direct
Shares
−1.37K
Price / share
$44.76
Trade value
$61.41K
% of position
3.9%
1/6/2021
35.18K→33.81K
Common Stock
Direct
Shares
−986.00
Price / share
$45.46
Trade value
$44.83K
% of position
2.9%
1/6/2021
33.81K→32.82K
Total
Net shares
−2.40K
Net value
-$108.17K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/5/2021 | S · Sale | −43.00 | $44.95 | $1.93K | 0.1% | 35.22K | 35.18K |
| Common Stock Direct | 1/6/2021 | S · Sale | −1.37K | $44.76 | $61.41K | 3.9% | 35.18K | 33.81K |
| Common Stock Direct | 1/6/2021 | S · Sale | −986.00 | $45.46 | $44.83K | 2.9% | 33.81K | 32.82K |
| Total | −2.40K | -$108.17K | ||||||
Derivative Transactions0
No derivative transactions reported